Highlights From The 4th Global Precision Medicine & Biomarkers Leaders Summit
Posted 21st February 2018 by Jane Williams
With just 3 months to go until the Precision Medicine & Biomarkers Leaders Summit: USA, we have taken some time to reflect on the Euopean Precision Medicine & Biomarkers Leaders Summit that took place in Munich in September.
Over the course of two days, expert speakers examined ground-breaking research in biomarkers, companion diagnostics, immuno-oncology, genomics, big data and AI, with the goal in mind of facilitating the development of impactful personalised treatments for patients.
- Keynote presentation ‘The Future of Personalised Healthcare: The Interplay of Diseases, Information and Technologies’ from Miro Venturi, Global Head Diagnostics Biomarkers & Personalised Healthcare, Roche Diagnostics Division.
- Executive panel discussion on Artificial Intelligence and machine learning, where experts examined the paradigm shift AI is bringing to Pharma R&D.
- Roundtable discussions on the potential of big data, advancing liquid biopsies, successful companion diagnostic partnerships, the future of precision medicine and immuno-oncology.
We are pleased to share a selection of presentation slides from the day:
Success Through Novel Collaborations, Value-added Services, and Early Patient Involvement
RNA Biomarker Discovery in Exosomes and Liquid Biopsies by Sequencing and qPCR
To identify new biomarkers and develop minimally invasive tests, Peter Mouritzen has developed a robust method for next-generation sequencing of small RNA in biofluids. In this presentation, he explores the new RNA Biomarker discoveries.
Precision Medicine in Rheumatology
What is the biggest inefficiency of most health care systems in terms of drug spendings? Here, Thierry Wurch explores the biggest breakthrough therapies in oncology in the last decade.
Leave a Reply